Journal of Clinical Oncology - ASCO Publications
WEBSep 9, 2024 · A world where cancer is prevented or cured. Founded in 1964, the American Society of Clinical Oncology, Inc. (ASCO®) is committed to making a world of difference in cancer care. Through research, education, and promotion of the highest-quality, equitable patient care, ASCO works to conquer cancer and create a …
ASCO Publications
WEBASCO’s publications—including the Society’s flagship publication, the Journal of Clinical Oncology —serve readers as the most credible, authoritative, peer-reviewed resources for significant clinical oncology research that informs the delivery of high-quality patient care across the globe. Latest from our Journals. Journal of Clinical ...
ASCO Clinical Practice Guidelines | Journal of Clinical Oncology
WEBFor more information on these guidelines, including information about planned guidelines, please access the ASCO.org guidelines page. Clinical practice guidelines serve as a guide for doctors and outline appropriate methods of treatment and care. Guidelines can address specific clinical situations (disease-oriented) or use of approved medical ...
Journal of Clinical Oncology: Vol 42, No 27 - ASCO Publications
WEB2 days ago · Pertuzumab Plus Trastuzumab in Patients With Biliary Tract Cancer With ERBB2/3 Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study
JCO Oncology Practice - ASCO Publications
WEBAug 12, 2024 · A world where cancer is prevented or cured. Founded in 1964, the American Society of Clinical Oncology, Inc. (ASCO®) is committed to making a world of difference in cancer care. Through research, education, and promotion of the highest-quality, equitable patient care, ASCO works to conquer cancer and create a …
ASCO Annual Meeting | ASCO Daily News
WEBJune 19, 2024. Dr. Diwakar Davar and Dr. Jason Luke discuss advances in the neoadjuvant immunotherapy space that were presented at the 2024 ASCO Annual Meeting, including promising outcomes in high-risk melanoma from the NADINA trial, as well as other new treatment options for patients with advanced cancers. Breast Cancer.
WEBThe rst ASCO guideline for antiemetics was published fi in 1999,1with updates in 2006,22011,32015,4and 2017.5 This update of the 2017 guideline provides guidance on the use of dexamethasone as a pro-phylactic antiemetic in patients receiving CPIs. This guideline update addresses programmed death-1 (PD-1), programmed death 1 …
Antiemetics: ASCO Guideline Update | Journal of Clinical Oncology
WEBJul 13, 2020 · The first ASCO guideline for antiemetics was published in 1999, 1 with updates in 2006, 2 2011, 3 2015, 4 and 2017. 5 This update of the 2017 guideline provides guidance on the use of dexamethasone as a prophylactic antiemetic in patients receiving CPIs. This guideline update addresses programmed death-1 (PD-1), programmed death 1–ligand (PD ...
Management of Cancer Cachexia: ASCO Guideline
WEBPURPOSE To provide evidence-based guidance on the clinical management of cancer cachexia in adult patients with advanced cancer. METHODS A systematic review of the literature collected evidence regarding nutritional, pharmacologic, and other interventions, such as exercise, for cancer cachexia. PubMed and the Cochrane Library were searched for randomized controlled trials (RCTs) and systematic ...
Management of Immune-Related Adverse Events in Patients …
WEBPURPOSE To increase awareness, outline strategies, and offer guidance on the recommended management of immune-related adverse events (irAEs) in patients treated with immune checkpoint inhibitor (ICPi) therapy. METHODS A multidisciplinary panel of medical oncology, dermatology, gastroenterology, rheumatology, pulmonology, endocrinology, neurology, hematology, emergency medicine, nursing ...